H. David Friedland
- Infectious Diseases top 1%
- Pharmacology top 1%
- Epidemiology top 5%
- Clinical Biochemistry top 0.5%
- Molecular Medicine top 1%
- Co-authors
- Dirk ThyeG. Ralph CoreyIan A. CritchleyGeorge H. TalbotPaul B. EckburgLily LlorensSteven L. BarriereMichael M. Kitt
- Topics
- Antimicrobial Resistance in Staphylococcus (26 papers)Pneumonia and Respiratory Infections (23 papers)Antibiotics Pharmacokinetics and Efficacy (19 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
H. David Friedland
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 958
- Pharmacology 594
- Epidemiology 529
- Clinical Biochemistry 440
- Molecular Medicine 345
Countries citing papers authored by H. David Friedland
This map shows the geographic impact of H. David Friedland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. David Friedland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. David Friedland more than expected).
Fields of papers citing papers by H. David Friedland
This network shows the impact of papers produced by H. David Friedland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. David Friedland. The network helps show where H. David Friedland may publish in the future.
Co-authorship network of co-authors of H. David Friedland
This figure shows the co-authorship network connecting the top 25 collaborators of H. David Friedland. A scholar is included among the top collaborators of H. David Friedland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. David Friedland. H. David Friedland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 39 | |
| 3 | 9 | |
| 4 | 21 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | 6 | |
| 8 | 5 | |
| 9 | 32 | |
| 10 | 6 | |
| 11 | 13 | |
| 12 | 13 | |
| 13 | 33 | |
| 14 | 41 | |
| 15 | 1 | |
| 16 | 195 | |
| 17 | 146 | |
| 18 | 196 | |
| 19 | 93 | |
| 20 | 236 |
About H. David Friedland
H. David Friedland is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (26 papers), Pneumonia and Respiratory Infections (23 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). The work is most often cited by research in Molecular Medicine (345 citations), Applied Microbiology and Biotechnology (139 citations) and Clinical Biochemistry (440 citations). H. David Friedland has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Dirk Thye, G. Ralph Corey, Ian A. Critchley, George H. Talbot, Paul B. Eckburg, Lily Llorens, Steven L. Barriere, Michael M. Kitt, Gary W. Witherell and Alena Jandourek. Their work appears in journals such as Clinical Infectious Diseases, CHEST Journal and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.